Global University Venturing

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Deep Genomics will use the money to advance drug candidates created through its AI drug development model, based on research by Toronto faculty.

Alexandria Venture Investments has helped UW's genetic sequencing technology developer TwinStand raise series A financing.

The former Strada Education managing director has been selected to oversee a newly-launched WGU venture fund targeting the education space.

University of Auckland Inventors Fund has contributed to a $40m series B round for AI-based avatar developer Soul Machines, with the investment led by Temasek.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Galecto, based on research at Lund and Edinburgh universities, is merging with PharmAkea, with the joint entity retaining the Galecto name and leadership team.

The colectomy-focused robotic surgical device developer has now assembled $51.7m having spun out from University of Nebraska Medical Center in 2006.

Inserm Transfer Initiative featured in the first round for VectivBio, a short bowel syndrome treatment developer spun out of Therachon following the latter's acquisition by Pfizer.

Paris Descartes University's gene therapy developer has raised $42.1m altogether following a series B featuring existing investors including Inserm Transfert Initiative.

Altair has picked up computational electromagnetics software developer NewFasant, based on the research of University of Alcalá associate professor Lorena Lozano Plata.